Diagnostics — Other Cost and Expense, Operating
Labcorp Holdings Diagnostics — Other Cost and Expense, Operating decreased by 1.8% to $438.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.8%, from $430.20M to $438.00M. Over 2 years (FY 2022 to FY 2025), Diagnostics — Other Cost and Expense, Operating shows an upward trend with a 14.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
A rising trend in other operating expenses may indicate bloated administrative overhead or rising facility costs, while a downward trend suggests successful cost-containment initiatives.
Detailed definition
This captures all remaining operating costs for the diagnostics segment not categorized as labor, supplies, or depreciat...
Peer comparison
Standard category for overhead and indirect costs in segment-level financial reporting.
lh_segment_diagnostics_other_cost_and_expense_operatingHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $344.15M | $344.15M | $344.15M | $344.15M | $384.00M | $384.00M | $403.40M | $416.60M | $426.70M | $430.20M | $454.20M | $462.80M | $446.00M | $438.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +11.6% | +0.0% | +5.1% | +3.3% | +2.4% | +0.8% | +5.6% | +1.9% | -3.6% | -1.8% |
| YoY Change | — | — | — | — | +11.6% | +0.0% | — | — | — | +12.0% | +12.6% | +11.1% | +4.5% | +1.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's diagnostics — other cost and expense, operating?
- Labcorp Holdings (LH) reported diagnostics — other cost and expense, operating of $438.00M in Q1 2026.
- How has Labcorp Holdings's diagnostics — other cost and expense, operating changed year-over-year?
- Labcorp Holdings's diagnostics — other cost and expense, operating increased by 1.8% year-over-year, from $430.20M to $438.00M.
- What is the long-term trend for Labcorp Holdings's diagnostics — other cost and expense, operating?
- Over 2 years (2022 to 2025), Labcorp Holdings's diagnostics — other cost and expense, operating has grown at a 14.1% compound annual growth rate (CAGR), from $1.38B to $1.79B.
- What does diagnostics — other cost and expense, operating mean?
- Miscellaneous operating expenses for the diagnostics segment excluding labor, supplies, and depreciation.